SpecificiT Pharma Inc., a privately held biopharmaceutical company focused on developing innovative personalized cancer immunotherapies. SpecificiT is developing cellular therapies for hematological cancers which to date, cannot be treated with chimeric antigen receptor modified T cells (CAR-T) therapies. SpecificiT’s unique approach is centered on the use of Minor Histocompatability Antigens (“MiHAs”) which enable donor T-cells to be safely directed to eliminate cancer cells in a patient.
Looking for a particular SpecificiT Pharma Inc. employee's phone or email?
The SpecificiT Pharma Inc. annual revenue was $608000 in 2026.
SpecificiT Pharma Inc. is based in Montreal, Quebec.
The NAICS codes for SpecificiT Pharma Inc. are [54171, 54, 541, 5417, 541711].
The SIC codes for SpecificiT Pharma Inc. are [283, 28, 80].